Entry |
|
Name |
Zasocitinib (USAN/INN) |
Formula |
C23H24N8O3
|
Exact mass |
460.1971
|
Mol weight |
460.49
|
Structure |

|
Efficacy |
Anti-inflammatory, Tyrosine kinase 2 inhibitor |
Comment |
Treatment of plaque psoriasis and psoriatic arthritis
|
Target |
|
Pathway |
hsa04620 | Toll-like receptor signaling pathway |
hsa04621 | NOD-like receptor signaling pathway |
hsa04658 | Th1 and Th2 cell differentiation |
|
Brite |
Target-based classification of drugs [BR:br08310]
Protein kinases
Non-receptor tyrosine kinases
JAK family
TYK2
D12941 Zasocitinib (USAN/INN)
|
Other DBs |
|
LinkDB |
|
KCF data |
ATOM 34
1 C8y C 13.5100 -14.8400
2 C8x C 13.5100 -16.2400
3 C8y C 14.7224 -16.9400
4 N4y N 15.9349 -16.2400
5 C8y C 15.9349 -14.8400
6 N5x N 14.7224 -14.1400
7 N5x N 17.2664 -16.6726
8 C8x C 18.0893 -15.5400
9 C8y C 17.2664 -14.4074
10 N1b N 12.2976 -14.1400
11 C8y C 11.1021 -14.8304
12 C8y C 9.9147 -14.1450
13 N4y N 8.7023 -14.8450
14 C8x C 8.7024 -16.2450
15 C8x C 9.8898 -16.9305
16 C8x C 11.1022 -16.2304
17 O5x O 9.9145 -12.7402
18 C8y C 7.4710 -14.1341
19 N5x N 7.4711 -12.7401
20 C8x C 6.2587 -12.0400
21 C8x C 5.0462 -12.7399
22 C8x C 5.0461 -14.1339
23 C8x C 6.2585 -14.8340
24 C5a C 17.6975 -13.0806
25 N1b N 19.0769 -12.7874
26 O5a O 16.7711 -12.0515
27 C1y C 20.0394 -13.8561
28 C1x C 20.0239 -15.2600
29 C1x C 21.4278 -15.2755
30 C1y C 21.4432 -13.8716
31 O2a O 22.4327 -12.9034
32 C1a C 23.7853 -13.2816
33 N1b N 14.7224 -18.3398
34 C1a C 13.4932 -19.0497
BOND 38
1 1 2 1
2 2 3 2
3 3 4 1
4 4 5 1
5 5 6 1
6 1 6 2
7 7 8 2
8 8 9 1
9 5 9 2
10 1 10 1
11 10 11 1
12 11 12 1
13 12 13 1
14 13 14 1
15 14 15 2
16 15 16 1
17 11 16 2
18 12 17 2
19 13 18 1
20 18 19 2
21 19 20 1
22 20 21 2
23 21 22 1
24 22 23 2
25 18 23 1
26 9 24 1
27 24 25 1
28 24 26 2
29 27 25 1 #Up
30 27 28 1
31 28 29 1
32 29 30 1
33 27 30 1
34 30 31 1 #Down
35 31 32 1
36 7 4 1
37 3 33 1
38 33 34 1
|